Most cited papers from Biotest (United States)

Biotest (United States)

What are the most cited papers from Biotest (United States)?

The most cited paper from Biotest (United States) is "BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity" (Leonard T. Heffner, Sundar Jagannath, Todd M. Zimmerman et al., 2012), with 62 citations. Next come "Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients" (45) and "BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma" (44).

Published TypeFieldAccess

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity Leonard T. Heffner, Sundar Jagannath, Todd M. Zimmerman et al. · Blood	16 Nov 2012	62
2	Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients Harry W. Schroeder, Christopher J. Dougherty · Infection Open access	11 Sep 2012	45
3	BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma Sundar Jagannath, Asher Alban Chanan-Khan, Leonard T. Heffner et al. · Blood	18 Nov 2011	44
4	Indatuximab Ravtansine (BT062) in Combination with Lenalidomide and Low-Dose Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma: Clinical Activity in Patients Already Exposed to Lenalidomide and Bortezomib Kevin R. Kelly, Asher Alban Chanan-Khan, Leonard T. Heffner et al. · Blood	6 Dec 2014	44
5	Indatuximab Ravtansine (BT062) In Combination With Lenalidomide and Low-Dose Dexamethasone In Patients With Relapsed and/Or Refractory Multiple Myeloma: Clinical Activity In Len/Dex-Refractory Patients Kevin R. Kelly, Asher Alban Chanan-Khan, George Somlo et al. · Blood	15 Nov 2013	30
6	HUMAN CYTOMEGALOVIRUS EARLY INFECTION, ACUTE REJECTION, AND MAJOR HISTOCOMPATIBILITY CLASS II EXPRESSION IN TRANSPLANTED LUNG Eloisa Arbustini, Patrizia Morbini, Maurizia Grasso et al. · Transplantation	Feb 1996	26
7	Az első két sikeres, convalescens friss fagyasztott plazmával történő terápia hazai alkalmazása intenzív osztályon kezelt, kritikus állapotú, COVID–19-fertőzésben szenvedő betegekben. Ilona Bobek, László Gopcsa, Marienn Réti et al. · Orvosi Hetilap Open access	Jul 2020	23
8	Genetic Association in Myocardial Infarction: Ethnicity; ABO, Rh, Lea, Xga Blood Groups; G6PD Deficiency; and Abnormal Haemoglobins Nirmalya Saha, C. C. S. Toh, Mahua Ghosh · Journal of Medical Genetics Open access	Dec 1973	20
9	Inhibitory activities of Ficus benghalensis bark against carbohydrate hydrolyzing enzymes - An in vitro study Faiyaz Ahmed, Shailesh Chavan, Ann Susan Satish et al. · Pharmacognosy Journal	Feb 2011	20
10	Effective virus inactivation and removal by steps of Biotest Pharmaceuticals IGIV production process Herbert O. Dichtelmüller, Eckhard Flechsig, Frank Sananes et al. · Results in Immunology Open access	2012	14
11	Three-generation Investigation on Serotonin Content in Rat Immune Cells long after β-endorphin Exposure in Late Pregnancy G Csaba, C. Karabélyos, Á Inczefi-Gonda et al. · Hormone and Metabolic Research	Mar 2005	13
12	Evaluating the formulae for integrated lethality in ethylene oxide sterilization using six different endospore forming strains of bacteria, and comparisons of integrated lethality for ethylene oxide and steam systems. Gregg A. Mosley, John R. Gillis, Garrett Krushefski · PubMed	28 Apr 2005	13
13	Broad neutralization of hepatitis C virus‐resistant variants by Civacir hepatitis C immunoglobulin Rajiv G. Tawar, Laura Heydmann, C Bach et al. · Hepatology Open access	17 Aug 2016	11
14	Assessment of bioburden on human and animal tissues: Part 1—Results of method development and validation studies John B. Kowalski, Gregg A. Mosley, Karen Merritt et al. · Cell and Tissue Banking	7 Jan 2011	9
15	Interpreting and understanding microbial data in validation of ethylene oxide sterilization processes. Gregg A. Mosley, Clark C Houghtling · PubMed	15 May 2007	7
16	Operating precision of steam BIER vessels and the interactive effects of varying Z values on the reproducibility of listed D values. Gregg A. Mosley, John R. Gillis · PubMed	11 Feb 2003	4
17	Combined repeated-dose and reproductive/developmental toxicity screening test of 3-amino-5-mercapto-1,2,4-triazole in rats Junichi Kikuchi, Sunao Aso, Takayuki Koga et al. · The Journal of Toxicological Sciences Open access	2013	4
18	Immunological evaluation of inactivated Newcastle disease vaccine depending on adjuvant composition A. I. Chegrynets, О. О. Saliy, I. A. Sobko et al. · Regulatory Mechanisms in Biosystems Open access	16 Jul 2021	3
19	Evaluation of the Suitability of a Commercially Available ELISA Test as a Monitoring Tool for Estimating the Salmonella Prevalence of Commercial Swine Herds Ágnes Szaszák, Thomas G. Blaha, John Deen et al. · International Conference on the Epidemiology and Control of Biological, Chemical and Physical Hazards in Pigs and Pork Conference paperOpen access	2001	2
20	Immunogenicity and duration of immunity of the polyvalent vaccine against chicken salmonellosis О М Сень, О. О. Saliy, V. I. Mazurkevych et al. · Regulatory Mechanisms in Biosystems Open access	11 Nov 2020	1
21	Epigenetic background of the most common non-oncologic gynecological diseases József Gábor Joó, Éva Csatlós, Réka Brubel et al. · Orvosi Hetilap Open access	Mar 2014	1
22	The pulmonological manifestations of rheumatoid arthritis György Bernscherer, Csaba Karabélyos, Zsolt Tarján · Orvosi Hetilap	Jul 2008	1
23	SELECTION OF CANDIDATE STRAIN FOR VACCINE AGAINST BOVINE CORONAVIRUS PRODUCTION A. Berezenko, В. В. Недосеков, F. S. Vabishchevych et al. · Scientific and Technical Bulletin оf State Scientific Research Control Institute of Veterinary Medical Products and Fodder Additives аnd Institute of Animal Biology Open access	7 Oct 2021	0
24	The Innovative Factor VIII Molecules HAT and HAT RI Overcome Impairments of Hemophilia A Therapy P Herbener, J Daufenbach, K Winterling et al. · Hämostaseologie Conference paper	Jun 2021	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.